On August 13, 2026, the clinical trial registry recorded a status update for NCT06326047, a study titled "A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes." The trial has reached Phase 2 and its status is listed as completed.
According to the registry entry, the study was designed to compare different doses of NN0519-0130 in people with type 2 diabetes, evaluating effects on blood sugar levels. The listing does not include specific results or outcome data at this time. No efficacy or safety conclusions are stated in the available record.
This update reflects only the change in trial status as recorded on ClinicalTrials.gov. It does not indicate whether findings have been published or what those findings may show. Readers seeking further detail can consult the official registry listing linked with this brief.
For background on tirzepatide, including its approved uses and regulatory status, readers can refer to the compound overview.